Atlas Trials

N99-02: Melphalan and Buthionine Sulfoximine

Clinical trial NCT00005835 · COMPLETED

Trial details

NCT number
NCT00005835
Sponsor
New Approaches to Neuroblastoma Therapy Consortium
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Neuroblastoma
Start date
2001-08-01
Primary completion
2014-12-01
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.